See also this year's filing and all EDGAR filings for this company.
PDF Report 0001048477_2026_Biomarin_Pharmaceutical_INC.pdf
Logs
Graph
Absolute values for 0001048477, Biomarin Pharmaceutical INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 3,953,490,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 410,036,000 |
| 2 | PropertyPlantAndEquipmentNet | 952,508,000 |
| 3 | remainder_Assets | 2,277,988,000 |
| 4 | LiabilitiesCurrent | 759,031,000 |
| 5 | LiabilitiesNoncurrent | 150,816,000 |
| 6 | remainder_Liabilities | 597,176,000 |
| 7 | CostOfGoodsAndServicesSold | 796,751,724 |
| 8 | SellingGeneralAndAdministrativeExpense | 1,528,717,002 |
| 9 | ResearchAndDevelopmentExpense | 1,050,303,769 |
| 10 | remainder_Expenses | 162,755,779 |
| 11 | remainder_Revenues | 3,115,840,501 |
| 12 | remainder_NetIncome | 91,995,780 |
| 13 | remainder_ComprehensiveNetIncome | 78,251,141 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 7,594,022,000 |
| 1 | Liabilities | 1,507,023,000 |
| 2 | Expenses | 3,538,528,274 |
| 3 | Revenues | 3,115,840,501 |
| 4 | StockholdersEquity | 6,086,999,000 |
| 5 | NetIncome | -330,691,993 |
| 6 | ComprehensiveNetIncome | -291,566,422 |
| 7 | BaseVar | 7,962,830,348 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.85 |
| 9 | EconomicCapitalRatio | 3.59 |
Edgar->Model Mapping
Feature Distribution
Change over Time
